Maynard Um
-
-
-
-
-
-
-
BioAtla presents data on ozuriftamab vedotin for throat cancer treatment
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on BioAtla Inc. (BCAB)
-
-
-
-
-
-
-
BioAtla, Inc. (BCAB) Tops Q3 EPS by 19c
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

